ernest wollin, md, pe, facr wollin ventures incorporated sarasota, florida john j. heine, phd...

19
Ernest Wollin, MD, PE, FACR Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Wollin Ventures Incorporated Sarasota, Florida Sarasota, Florida John J. Heine, PhD John J. Heine, PhD Associate Professor Associate Professor Cancer Epidemiology Department Cancer Epidemiology Department H. Lee Moffitt Cancer Center & Research H. Lee Moffitt Cancer Center & Research Institute Institute Tampa, Florida Tampa, Florida Magnetic Resonance Electrical Impedance Mammography (MREIM): Computer Simulations of Clinical application and Theoretical Analysis

Upload: alexis-lawrence

Post on 26-Mar-2015

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Ernest Wollin, MD, PE, FACRErnest Wollin, MD, PE, FACRWollin Ventures IncorporatedWollin Ventures Incorporated

Sarasota, FloridaSarasota, Florida

John J. Heine, PhDJohn J. Heine, PhDAssociate ProfessorAssociate Professor

Cancer Epidemiology DepartmentCancer Epidemiology DepartmentH. Lee Moffitt Cancer Center & Research InstituteH. Lee Moffitt Cancer Center & Research Institute

Tampa, FloridaTampa, Florida

Magnetic Resonance Electrical Impedance Mammography (MREIM): Computer

Simulations of Clinical application and Theoretical Analysis

Page 2: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee
Page 3: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

MREIM is an emerging technology in the earliest stage of development

Combines magnetic resonance (MR) breast imaging with Electrical Impedance Scanning (EIS) to exploit electrical conductivity differences between normal and malignant breast tissue

Electrical conductivity is a clinically validated and FDA approved (EIS Siemens TranScan 2000) biomarker for malignancy

Page 4: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

The MREIM Effect MREIM induces two observable effects because

malignant cells produces localized electrical conductivity differences in the adjacent stroma:

A frequency encode effect that manifests as a differential signal across the malignancy area

A phase encode effect that manifests as a differential signal about the malignancy border

These can be explained with Fourier Shift Theory of a Complex Feature Space

Page 5: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Experimental Grade MREIM DeviceExperimental Grade MREIM Device

Faraday shields attached to the stabilization paddles of a breast coil with the resistive coupling removed.

Page 6: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Bo field orthogonal to diagramBo field orthogonal to diagram Spherical tumor embedded within Spherical tumor embedded within

uniform normal tissue background uniform normal tissue background contained in skin surrogate bagcontained in skin surrogate bag

Alpha-dispersion low frequency Alpha-dispersion low frequency phase modulation voltage applied phase modulation voltage applied to the Faraday shields produces a to the Faraday shields produces a local periodic Bo magnetic field local periodic Bo magnetic field aberration in tumor induced aberration in tumor induced regions of higher electrical regions of higher electrical conductivityconductivity

High resistance vinyl plates High resistance vinyl plates insulate skin surrogate from insulate skin surrogate from Faraday shield conductorsFaraday shield conductors

Illustration of the MREIM phantom and hardware. The Illustration of the MREIM phantom and hardware. The entire assembly fits within the breast stabilization paddles entire assembly fits within the breast stabilization paddles

of a standard breast coilof a standard breast coil

Page 7: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

MREIM Simulations MREIM Simulations

• Simulate the MR image of the physical phantom placed within the Simulate the MR image of the physical phantom placed within the MREIM deviceMREIM device

Show control images with ample native MR contrast but with no Show control images with ample native MR contrast but with no MREIM effectsMREIM effects

Show both MREIM effects together with ample native MR image Show both MREIM effects together with ample native MR image contrastcontrast

Show the MREIM effects separately with ample native MR image Show the MREIM effects separately with ample native MR image contrastcontrast

Show the MREIM effects together when there is Show the MREIM effects together when there is no native MR no native MR image contrastimage contrast

Page 8: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

No EffectsNo Effects

Phase modulation voltage disconnected during the Phase modulation voltage disconnected during the entire imaging sequence entire imaging sequence

Page 9: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulated sequence without MREIM: This shows two statistically similar simulated raw (i.e. control) magnitude images (left and middle) with ample native MR image contrast. The image on the right shows the difference between the two control images. The two raw images are control images used in the following analyses. FOV 12.8 cm. Matrix 128x128. 60 Hz./pixel. 22mT/m

Control Image (C1) Control Image (C2)Difference Image

C1 - C2

Page 10: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Both EffectsBoth Effects Two Effects: apply the phase modulation voltage during

the entire MR imaging sequence

Page 11: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulated MREIM Effects Image: The magnitude image on the left was simulated with the MREIM phase modulation voltage connected during the entire image acquisition. The effects-on images (middle and right) show the difference between the left image and the control images. Frequency encoding is in the horizontal direction, phase encoding and

Bo field is in the vertical direction. i=10a/m2

Effects Image (E) Control and Effects Difference Image

E - C1

Control and Effects Difference Image

E – C2

Page 12: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Isolate the EffectsIsolate the Effects Frequency Encode Effect: apply the phase modulation

voltage during frequency encoding only

Page 13: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulated sequence with Isolated MREIM frequency encode effect: The magnitude image on the left was simulated with the MREIM phase modulation voltage applied during frequency encoding only. The effects-on images (middle and right) show the difference between the left image and the control images. This effect captures the tumor bed.

Frequency Encode Effect Image (EFE )

Control and Effect Difference Image

EFE - C1

Control and Effect Difference Image

EFE – C2

Page 14: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Isolate the Effects Phase Encode Effect: disconnect the phase modulation

voltage during frequency encoding

Page 15: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulated sequence with Isolated MREIM phase encode effect: The magnitude image on the left was simulated with the MREIM phase modulation voltage disconnected during frequency encoding. The effects-on images (middle and right) show the difference between the left image and the control images. This shows a differential signal in the regions where the electrical conductivity changes. Note: window and level were adjusted to emphasize the effects.

Phase Encode Effect Image ( EPE )

Control and Effect Difference Image

EPE - C1

Control and Effect Difference Image

EPE – C2

Page 16: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulation with no native MR image contrast

• Show electrical conductivity MREIM effects only

Page 17: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Simulated sequence with MREIM effects with no native image contrast. The magnitude image on the left is a simulated magnitude image with no native MR contrast. The middle image is the MREIM image acquired with the phase modulation voltage applied during the entire acquisition. The right image shows the difference between the left and middle images. This shows that the differential MREIM image is due to electrical conductivity changes only.

No native Contrast control Image ( CNC )

Effects Image (ENC ) Control and Effects Difference Image

ENC – CNC

Page 18: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Achievements Achievements • Experimental proof of concept previously presented Experimental proof of concept previously presented

• Theory and simulation agree with experiment Theory and simulation agree with experiment (see (see poster presentation for experimental imaging results)poster presentation for experimental imaging results)

• The Faraday shield resistive coupling provides the The Faraday shield resistive coupling provides the

design for a patient grade MREIM device by modifying design for a patient grade MREIM device by modifying the sagittal stabilization paddles of any breast coilthe sagittal stabilization paddles of any breast coil

• Doctoral dissertation: “Advances in Magnetic Doctoral dissertation: “Advances in Magnetic Resonance Impedance Mammography”, Nataliya Resonance Impedance Mammography”, Nataliya Kovalchuk. http:www.lib.usf.eduKovalchuk. http:www.lib.usf.edu

Page 19: Ernest Wollin, MD, PE, FACR Wollin Ventures Incorporated Sarasota, Florida John J. Heine, PhD Associate Professor Cancer Epidemiology Department H. Lee

Future ObjectivesFuture Objectives Industry support to provide clinical grade equipmentIndustry support to provide clinical grade equipment

Develop durable compliant phantom with stable electrical Develop durable compliant phantom with stable electrical and mechanical propertiesand mechanical properties

Perform phantom experiments to optimize MR sequence Perform phantom experiments to optimize MR sequence parametersparameters

Secure investigational device exemptionSecure investigational device exemption

Image BiRads 4 and 5 patients with FDA approved Image BiRads 4 and 5 patients with FDA approved apparatus at the H. Lee Moffitt Cancer Center and apparatus at the H. Lee Moffitt Cancer Center and Research InstituteResearch Institute